A carregar...
Better to be in The Placebo Arm for Trials of Neurological Therapies?
Patients with progressive neurodegenerative diseases often pursue trial entry seeking to access cutting edge therapies. However, cutting edge therapies for neurodegenerative diseases tend to have higher adverse event rates and underperform placebo. This essay argues that patients seeking trial entry...
Na minha lista:
| Publicado no: | Cell Transplant |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6041887/ https://ncbi.nlm.nih.gov/pubmed/29855198 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0963689718755708 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|